Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Clinical Translation and Validation of a Predictive Biomarker for Patritumab, an Anti-human Epidermal Growth Factor Receptor 3 (HER3) Monoclonal Antibody, in Patients With Advanced Non-small Cell Lung Cancer.

Mendell J, Freeman DJ, Feng W, Hettmann T, Schneider M, Blum S, Ruhe J, Bange J, Nakamaru K, Chen S, Tsuchihashi Z, von Pawel J, Copigneaux C, Beckman RA.

EBioMedicine. 2015 Feb 12;2(3):264-71. doi: 10.1016/j.ebiom.2015.02.005. eCollection 2015 Mar.

2.

Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy.

Siroky BJ, Yin H, Dixon BP, Reichert RJ, Hellmann AR, Ramkumar T, Tsuchihashi Z, Bunni M, Dillon J, Bell PD, Sampson JR, Bissler JJ.

Am J Physiol Renal Physiol. 2014 Sep 1;307(5):F560-70. doi: 10.1152/ajprenal.00569.2013. Epub 2014 Jun 11.

3.

Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events.

Shahabi V, Berman D, Chasalow SD, Wang L, Tsuchihashi Z, Hu B, Panting L, Jure-Kunkel M, Ji RR.

J Transl Med. 2013 Mar 22;11:75. doi: 10.1186/1479-5876-11-75.

4.

Efficacy of sequential treatment with sunitinib-everolimus in an orthotopic mouse model of renal cell carcinoma.

Larkin J, Esser N, Calvo E, Tsuchihashi Z, Fiedler U, Graeser R, Kim D.

Anticancer Res. 2012 Jul;32(7):2399-406.

PMID:
22753696
5.

Drug-diagnostic codevelopment strategies: FDA and industry dialog at the 4th FDA/DIA/PhRMA/PWG/BIO Pharmacogenomics Workshop.

Hinman L, Spear B, Tsuchihashi Z, Kelly J, Bross P, Goodsaid F, Kalush F.

Pharmacogenomics. 2009 Jan;10(1):127-36. doi: 10.2217/14622416.10.1.127.

6.

Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy.

Sabatine MS, Ploughman L, Simonsen KL, Iakoubova OA, Kirchgessner TG, Ranade K, Tsuchihashi Z, Zerba KE, Long DU, Tong CH, Packard CJ, Pfeffer MA, Devlin JJ, Shepherd J, Campos H, Sacks FM, Braunwald E.

Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):562-7. doi: 10.1161/ATVBAHA.107.156653. Epub 2008 Jan 3.

PMID:
18174457
7.

Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.

Lenz HJ, Van Cutsem E, Khambata-Ford S, Mayer RJ, Gold P, Stella P, Mirtsching B, Cohn AL, Pippas AW, Azarnia N, Tsuchihashi Z, Mauro DJ, Rowinsky EK.

J Clin Oncol. 2006 Oct 20;24(30):4914-21.

PMID:
17050875
8.

Asp92Asn polymorphism in the myeloid IgA Fc receptor is associated with myocardial infarction in two disparate populations: CARE and WOSCOPS.

Iakoubova OA, Tong CH, Chokkalingam AP, Rowland CM, Kirchgessner TG, Louie JZ, Ploughman LM, Sabatine MS, Campos H, Catanese JJ, Leong DU, Young BA, Lew D, Tsuchihashi Z, Luke MM, Packard CJ, Zerba KE, Shaw PM, Shepherd J, Devlin JJ, Sacks FM.

Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2763-8. Epub 2006 Sep 28.

PMID:
17008591
9.

Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke.

Ranade K, Kirchgessner TG, Iakoubova OA, Devlin JJ, DelMonte T, Vishnupad P, Hui L, Tsuchihashi Z, Sacks FM, Sabatine MS, Braunwald E, White TJ, Shaw PM, Dracopoli NC.

Stroke. 2005 Nov;36(11):2346-50. Epub 2005 Oct 20.

PMID:
16239632
10.

Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations.

Mukohara T, Engelman JA, Hanna NH, Yeap BY, Kobayashi S, Lindeman N, Halmos B, Pearlberg J, Tsuchihashi Z, Cantley LC, Tenen DG, Johnson BE, Jänne PA.

J Natl Cancer Inst. 2005 Aug 17;97(16):1185-94.

PMID:
16106023
11.

Responsiveness to cetuximab without mutations in EGFR.

Tsuchihashi Z, Khambata-Ford S, Hanna N, Jänne PA.

N Engl J Med. 2005 Jul 14;353(2):208-9. No abstract available.

PMID:
16014894
12.
13.

The discovery of the new haemochromatosis gene. 1996.

Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A.

J Hepatol. 2003 Jun;38(6):704-9. No abstract available.

PMID:
12763361
14.

Progress in high throughput SNP genotyping methods.

Tsuchihashi Z, Dracopoli NC.

Pharmacogenomics J. 2002;2(2):103-10. Review.

PMID:
12049172
15.

Transferrin receptor mutation analysis in hereditary hemochromatosis patients.

Tsuchihashi Z, Hansen SL, Quintana L, Kronmal GS, Mapa FA, Feder JN, Wolff RK.

Blood Cells Mol Dis. 1998 Sep;24(3):317-21.

PMID:
10087990
16.

The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding.

Feder JN, Penny DM, Irrinki A, Lee VK, Lebrón JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC.

Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1472-7.

17.

Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells.

Waheed A, Parkkila S, Zhou XY, Tomatsu S, Tsuchihashi Z, Feder JN, Schatzman RC, Britton RS, Bacon BR, Sly WS.

Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12384-9.

18.

The RNA polymerase II preinitiation complex formed in the presence of ATP.

Serizawa H, Tsuchihashi Z, Mizumoto K.

Nucleic Acids Res. 1997 Oct 15;25(20):4079-84.

19.

Mutation and haplotype analyses of the Werner's syndrome gene based on its genomic structure: genetic epidemiology in the Japanese population.

Matsumoto T, Imamura O, Yamabe Y, Kuromitsu J, Tokutake Y, Shimamoto A, Suzuki N, Satoh M, Kitao S, Ichikawa K, Kataoka H, Sugawara K, Thomas W, Mason B, Tsuchihashi Z, Drayna D, Sugawara M, Sugimoto M, Furuichi Y, Goto M.

Hum Genet. 1997 Jul;100(1):123-30.

PMID:
9225981
20.

The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression.

Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, Prass CE, Starnes SM, Wolff RK, Parkkila S, Sly WS, Schatzman RC.

J Biol Chem. 1997 May 30;272(22):14025-8.

21.

A 1.1-Mb transcript map of the hereditary hemochromatosis locus.

Ruddy DA, Kronmal GS, Lee VK, Mintier GA, Quintana L, Domingo R Jr, Meyer NC, Irrinki A, McClelland EE, Fullan A, Mapa FA, Moore T, Thomas W, Loeb DB, Harmon C, Tsuchihashi Z, Wolff RK, Schatzman RC, Feder JN.

Genome Res. 1997 May;7(5):441-56.

22.

Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract.

Parkkila S, Waheed A, Britton RS, Feder JN, Tsuchihashi Z, Schatzman RC, Bacon BR, Sly WS.

Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2534-9.

23.

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK.

Nat Genet. 1996 Aug;13(4):399-408.

PMID:
8696333
24.

Influence of human immunodeficiency virus nucleocapsid protein on synthesis and strand transfer by the reverse transcriptase in vitro.

Rodríguez-Rodríguez L, Tsuchihashi Z, Fuentes GM, Bambara RA, Fay PJ.

J Biol Chem. 1995 Jun 23;270(25):15005-11.

26.

An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis.

Herschlag D, Khosla M, Tsuchihashi Z, Karpel RL.

EMBO J. 1994 Jun 15;13(12):2913-24. Erratum in: EMBO J 1994 Aug 15;13(16):3926.

27.

Protein enhancement of hammerhead ribozyme catalysis.

Tsuchihashi Z, Khosla M, Herschlag D.

Science. 1993 Oct 1;262(5130):99-102.

PMID:
7692597
29.

Translational frameshifting in the Escherichia coli dnaX gene in vitro.

Tsuchihashi Z.

Nucleic Acids Res. 1991 May 11;19(9):2457-62.

30.

Translational frameshifting generates the gamma subunit of DNA polymerase III holoenzyme.

Tsuchihashi Z, Kornberg A.

Proc Natl Acad Sci U S A. 1990 Apr;87(7):2516-20.

31.
32.

Supplemental Content

Loading ...
Support Center